BiomX Inc
Urania Rappo, MD is Senior Director of clinical development at BiomX, a biotech company developing phage cocktails designed to target and destroy harmful bacteria. Prior to joining BiomX in 2020, Dr Rappo worked on the clinical development of dalbavancin and other anti-infectives at Durata Therapeutics and Allergan. As an adult infectious disease physician, she focuses on developing safer and more effective treatment options for difficult to treat infections.
She earned her undergraduate degree at Barnard College, her Pharm.D. at Arnold & Marie Schwartz College of Pharmacy and Health Sciences of Long Island University, her M.D. at Drexel University College of Medicine, and her M.S. in Clinical Epidemiology and Health Services Research at Weill Cornell Graduate School of Medical Sciences. She completed her residency in internal medicine at NYU School of Medicine, her fellowship in infectious diseases at Memorial Sloan-Kettering Cancer Center, and her National Research Service Award fellowship / T32 training program at Weill Cornell Medical College. She is a member of the Alpha Omega Alpha Honor Medical Society and a Fellow of the Infectious Diseases Society of America (IDSA).
Saturday, September 28, 2024
10:15 AM – 12:15 PM ET